These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38493484)

  • 1. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.
    Onida F; Gagelmann N; Chalandon Y; Kobbe G; Robin M; Symeonidis A; de Witte T; Itzykson R; Jentzsch M; Platzbecker U; Santini V; Sanz G; Scheid C; Solary E; Valent P; Greco R; Sanchez-Ortega I; Yakoub-Agha I; Pleyer L
    Blood; 2024 May; 143(22):2227-2244. PubMed ID: 38493484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation.
    Desai A; Samara Y; Yang D; Ball B; Braun A; Koller P; Blackmon A; Agrawal V; Pourhassan H; Amanam I; Arslan S; Otoukesh S; Sandhu K; Aldoss I; Ali H; Salhotra A; Al Malki MM; Artz A; Becker P; Smith E; Stein A; Marcucci G; Forman SJ; Curtin P; Nakamura R; Pullarkat V
    Leuk Res; 2024 Oct; 145():107565. PubMed ID: 39208597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis.
    Robin M; de Wreede LC; Padron E; Bakunina K; Fenaux P; Koster L; Nazha A; Beelen DW; Rampal RK; Sockel K; Komrokji RS; Gagelmann N; Eikema DJ; Radujkovic A; Finke J; Potter V; Killick SB; Legrand F; Solary E; Broom A; Garcia-Manero G; Rizzoli V; Hayden P; Patnaik MM; Onida F; Yakoub-Agha I; Itzykson R
    Blood; 2022 Sep; 140(12):1408-1418. PubMed ID: 35667047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
    Rovó A; Gras L; Piepenbroek B; Kröger N; Reinhardt HC; Radujkovic A; Blaise D; Kobbe G; Niityvuopio R; Platzbecker U; Sockel K; Hunault-Berger M; Cornelissen JJ; Forcade E; Bourhis JH; Chalandon Y; Kinsella F; Nguyen-Quoc S; Maertens J; Elmaagacli A; Mordini N; Hayden P; Raj K; Drozd-Sokolowska J; de Wreede LC; McLornan DP; Robin M; Yakoub-Agha I; Onida F
    Am J Hematol; 2024 Feb; 99(2):203-215. PubMed ID: 38009469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.
    de Witte T; Bowen D; Robin M; Malcovati L; Niederwieser D; Yakoub-Agha I; Mufti GJ; Fenaux P; Sanz G; Martino R; Alessandrino EP; Onida F; Symeonidis A; Passweg J; Kobbe G; Ganser A; Platzbecker U; Finke J; van Gelder M; van de Loosdrecht AA; Ljungman P; Stauder R; Volin L; Deeg HJ; Cutler C; Saber W; Champlin R; Giralt S; Anasetti C; Kröger N
    Blood; 2017 Mar; 129(13):1753-1762. PubMed ID: 28096091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
    Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S;
    Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP.
    Onida F; Sbianchi G; Radujkovic A; Sockel K; Kröger N; Sierra J; Socié G; Cornelissen J; Poiré X; Raida L; Bourhis JH; Finke J; Passweg J; Salmenniemi U; Schouten HC; Beguin Y; Martin S; Deconinck E; Ganser A; Zver S; Lioure B; Rohini R; Koster L; Hayden P; Iacobelli S; Robin M; Yakoub-Agha I
    Bone Marrow Transplant; 2022 Jun; 57(6):896-902. PubMed ID: 35352038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia.
    Gagelmann N; Bogdanov R; Stölzel F; Rautenberg C; Panagiota V; Becker H; Radujkovic A; Luft T; Christopeit M; Finke J; Platzbecker U; Ditschkowski M; Schroeder T; Koldehoff M; Heuser M; Kobbe G; Beelen DW; Germing U; Kröger N
    Transplant Cell Ther; 2021 Jan; 27(1):95.e1-95.e4. PubMed ID: 33039516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
    Liu HD; Ahn KW; Hu ZH; Hamadani M; Nishihori T; Wirk B; Beitinjaneh A; Rizzieri D; Grunwald MR; Sabloff M; Olsson RF; Bajel A; Bredeson C; Daly A; Inamoto Y; Majhail N; Saad A; Gupta V; Gerds A; Malone A; Tallman M; Reshef R; Marks DI; Copelan E; Gergis U; Savoie ML; Ustun C; Litzow MR; Cahn JY; Kindwall-Keller T; Akpek G; Savani BN; Aljurf M; Rowe JM; Wiernik PH; Hsu JW; Cortes J; Kalaycio M; Maziarz R; Sobecks R; Popat U; Alyea E; Saber W
    Biol Blood Marrow Transplant; 2017 May; 23(5):767-775. PubMed ID: 28115276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
    Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary treatment approaches to CMML - Is allogeneic HCT the only cure?
    Robin M; Itzykson R
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101138. PubMed ID: 32460980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia].
    Zhang XH; Zhou JY
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):18-21. PubMed ID: 38527833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
    Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2039-2051. PubMed ID: 26428082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
    Park S; Labopin M; Yakoub-Agha I; Delaunay J; Dhedin N; Deconinck E; Michallet M; Robin M; De Revel T; Bernard M; Vey N; Lioure B; Lapusan S; Tabrizi R; Bourhis JH; Huynh A; Beguin Y; Socié G; Dreyfus F; Fenaux P; Mohty M
    Eur J Haematol; 2013 May; 90(5):355-64. PubMed ID: 23320648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
    Ortí G; Gras L; Zinger N; Finazzi MC; Sockel K; Robin M; Forcade E; Avenoso D; Kröger N; Finke J; Radujkovic A; Hunault-Berger M; Schroyens W; Zuckerman T; Bourhis JH; Chalandon Y; Bloor A; Schots R; de Wreede LC; Drozd-Sokolowska J; Raj K; Polverelli N; Czerw T; Hernández-Boluda JC; McLornan D; Yakoub-Agha I
    Am J Hematol; 2023 Apr; 98(4):628-638. PubMed ID: 36606718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
    Yucel OK; Saliba RM; Rondon G; Ahmed S; Alousi A; Bashir Q; Ciurea SO; Popat U; Khouri I; Marin D; Rezvani K; Kebriaei P; Shpall EJ; Champlin RE; Oran B
    Cancer; 2017 Jul; 123(14):2661-2670. PubMed ID: 28324640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party.
    McLornan DP; Sirait T; Hernández-Boluda JC; Czerw T; Hayden P; Yakoub-Agha I
    Curr Res Transl Med; 2021 Jan; 69(1):103267. PubMed ID: 33069640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia/lymphoma in first complete remission: a single-center study.
    Gu Z; Li F; Li M; Wang L; Lu N; Jin X; Wang L; Gao C; Dou L; Liu D
    Ann Hematol; 2024 Jul; 103(7):2445-2454. PubMed ID: 38605231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
    Kharfan-Dabaja MA; Kumar A; Ayala E; Hamadani M; Reimer P; Gisselbrecht C; d'Amore F; Jantunen E; Ishida T; Bazarbachi A; Foss F; Advani R; Fenske TS; Lazarus HM; Friedberg JW; Aljurf M; Sokol L; Tobinai K; Tse E; Burns LJ; Chavez JC; Reddy NM; Suzuki R; Ahmed S; Nademanee A; Mohty M; Gopal AK; Fanale MA; Pro B; Moskowitz AJ; Sureda A; Perales MA; Carpenter PA; Savani BN
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1826-1838. PubMed ID: 28797780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.